Hepion Pharmaceuticals, Inc.
Public company- Headquarters
- RED BANK, New Jersey
- Ticker
- CTRVP
- CIK
- 0001583771
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOGary Stetz | Oct 9, 2026 | Appointed |
| CEOSireesh Appajosyula, PharmD | Oct 9, 2026 | Appointed |
| directorJames Liddy | Aug 20, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- ELITE PHARMACEUTICALS INC /NV/
Class I director appointed: John W. LaRocca, Esq.
- Executive appointment
CFO appointed: Gary Stetz
Gary Stetz was named Chief Financial Officer of Hepion Pharmaceuticals, Inc., effective October 9, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 9, 2026Role: Chief Financial Officer
- Executive appointment
CEO appointed: Sireesh Appajosyula, PharmD
Sireesh Appajosyula, PharmD was named Chief Executive Officer of Hepion Pharmaceuticals, Inc., effective October 9, 2026. Sireesh Appajosyula, PharmD succeeds Gary Stetz. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 9, 2026Role: Chief Executive Officer
- Executive appointment
director appointed: James Liddy
James Liddy was named director of Hepion Pharmaceuticals, Inc., effective August 19, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 20, 2026Role: director
Last verified Nov 8, 2026